Phase I clinical trial of the bispecific antibody MDX-H210 (anti-Fc?RI × anti-HER-2/neu) in combination with Filgrastim (G-CSF) for treatment of advanced breast cancer.

Saved in:
Bibliographic Details
Title: Phase I clinical trial of the bispecific antibody MDX-H210 (anti-Fc?RI × anti-HER-2/neu) in combination with Filgrastim (G-CSF) for treatment of advanced breast cancer.
Authors: Repp, R.1 Roland.Repp@med3.imed.uni-erlangen.de, van Ojik, H.H.2,3, Valerius, T.1, Groenewegen, G.2, Wieland, G.4, Oetzel, C.1, Stockmeyer, B.1, Becker, W.5, Eisenhut, M.6, Steininger, H.7, Deo, Y.M.8, Blijham, G.H.2, Kalden, J.R.1, van de Winkel, J.G.J.3,9, Gramatzki, M.1
Source: British Journal of Cancer. 12/15/2003, Vol. 89 Issue 12, p2234-2243. 10p.
Database: Academic Search Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 11724118
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Phase I clinical trial of the bispecific antibody MDX-H210 (anti-Fc?RI × anti-HER-2/neu) in combination with Filgrastim (G-CSF) for treatment of advanced breast cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Repp%2C+R%2E%22">Repp, R.</searchLink><relatesTo>1</relatesTo><i> Roland.Repp@med3.imed.uni-erlangen.de</i><br /><searchLink fieldCode="AR" term="%22van+Ojik%2C+H%2EH%2E%22">van Ojik, H.H.</searchLink><relatesTo>2,3</relatesTo><br /><searchLink fieldCode="AR" term="%22Valerius%2C+T%2E%22">Valerius, T.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Groenewegen%2C+G%2E%22">Groenewegen, G.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Wieland%2C+G%2E%22">Wieland, G.</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Oetzel%2C+C%2E%22">Oetzel, C.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Stockmeyer%2C+B%2E%22">Stockmeyer, B.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Becker%2C+W%2E%22">Becker, W.</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Eisenhut%2C+M%2E%22">Eisenhut, M.</searchLink><relatesTo>6</relatesTo><br /><searchLink fieldCode="AR" term="%22Steininger%2C+H%2E%22">Steininger, H.</searchLink><relatesTo>7</relatesTo><br /><searchLink fieldCode="AR" term="%22Deo%2C+Y%2EM%2E%22">Deo, Y.M.</searchLink><relatesTo>8</relatesTo><br /><searchLink fieldCode="AR" term="%22Blijham%2C+G%2EH%2E%22">Blijham, G.H.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Kalden%2C+J%2ER%2E%22">Kalden, J.R.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22van+de+Winkel%2C+J%2EG%2EJ%2E%22">van de Winkel, J.G.J.</searchLink><relatesTo>3,9</relatesTo><br /><searchLink fieldCode="AR" term="%22Gramatzki%2C+M%2E%22">Gramatzki, M.</searchLink><relatesTo>1</relatesTo>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22British+Journal+of+Cancer%22">British Journal of Cancer</searchLink>. 12/15/2003, Vol. 89 Issue 12, p2234-2243. 10p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=11724118
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/sj.bjc.6601367
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 10
        StartPage: 2234
    Titles:
      – TitleFull: Phase I clinical trial of the bispecific antibody MDX-H210 (anti-Fc?RI × anti-HER-2/neu) in combination with Filgrastim (G-CSF) for treatment of advanced breast cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Repp, R.
      – PersonEntity:
          Name:
            NameFull: van Ojik, H.H.
      – PersonEntity:
          Name:
            NameFull: Valerius, T.
      – PersonEntity:
          Name:
            NameFull: Groenewegen, G.
      – PersonEntity:
          Name:
            NameFull: Wieland, G.
      – PersonEntity:
          Name:
            NameFull: Oetzel, C.
      – PersonEntity:
          Name:
            NameFull: Stockmeyer, B.
      – PersonEntity:
          Name:
            NameFull: Becker, W.
      – PersonEntity:
          Name:
            NameFull: Eisenhut, M.
      – PersonEntity:
          Name:
            NameFull: Steininger, H.
      – PersonEntity:
          Name:
            NameFull: Deo, Y.M.
      – PersonEntity:
          Name:
            NameFull: Blijham, G.H.
      – PersonEntity:
          Name:
            NameFull: Kalden, J.R.
      – PersonEntity:
          Name:
            NameFull: van de Winkel, J.G.J.
      – PersonEntity:
          Name:
            NameFull: Gramatzki, M.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 12
              Text: 12/15/2003
              Type: published
              Y: 2003
          Identifiers:
            – Type: issn-print
              Value: 00070920
          Numbering:
            – Type: volume
              Value: 89
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: British Journal of Cancer
              Type: main
ResultId 1